Molecular aspects of azoles-induced teratogenesis

Bibliography

• Wilson JW. Environment and birth defects (environmental science series). Academic Press, London; 1973
   Google Scholar
• Karnofsky DA. Drugs as teratogens in animals and man. Annu Rev Pharmacol 1965;10:447-72
   Google Scholar
• Caputo R. Itraconazole (sporanox) in superficial and systemic fungal infections. Expert Rev Anti Infect Ther 2003;1:531-42
   PubMedGoogle Scholar
• Zarn JA, Brüschweiler BJ, Schlatter JR. Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14alpha-demethylase and aromatase. Environ Health Perspect 2003;111:255-61
   PubMed Web of Science ®Google Scholar
• Dix DJ, Gallagher K, Benson WH, A framework for the use of genomics data at the EPA. Nat Biotechnol 2006;24:1108-11
   PubMed Web of Science ®Google Scholar
• Vanden Bossche H, Ausma J, Bohets H, The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob Agents Chemother 2004;48:3272-8
   PubMed Web of Science ®Google Scholar
• Georgopapadakou NH. Antifungals: mechanism of action and resistance, established and novel drugs. Curr Opin Microbiol 1998;1:547-57
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Aoyama Y, Noshiro M, Sterol 14-demethylase P450 (CYP51) provides a breakthrough for the discussion on the evolution of cytochrome P450 gene superfamily. Biochem Biophys Res Commun 2000;273:799-804
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Kazy Z, Vargha P. A population-based case-control teratological study of vaginal econazole treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2003;111:135-40
   PubMed Web of Science ®Google Scholar
• Rosa FW, Baum C, Shaw M. Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet Gynecol 1987;69:751-5
   PubMed Web of Science ®Google Scholar
• Inman W, Pearce G, Wilton L. Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy. Eur J Clin Pharmacol 1994;46:115-8
   PubMed Web of Science ®Google Scholar
• Mastroiacovo P, Mazzone T, Botto LD, Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. Am J Obstet Gynecol 1996;175:1645-50
   PubMed Web of Science ®Google Scholar
• Sorensen HT, Nielsen GL, Olesen C, Risk of malformations and other outcomes in children exposed to fluconazole in utero. Br J Clin Pharmacol 1999;48:234-8
   PubMed Web of Science ®Google Scholar
• Jick SS. Pregnancy outcomes after maternal exposure to fluconazole. Pharmacotherapy 1999;19:221-22
   PubMed Web of Science ®Google Scholar
• Campomori A, Bonati M. Fluconazole treatment for vulvovaginal candidiasis during pregnancy. Ann Pharmacother 1997;31:118-9
   PubMed Web of Science ®Google Scholar
• Nørgaard M, Pedersen L, Gislum M, Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. J Antimicrob Chemother 2008;62:172-6
   PubMed Web of Science ®Google Scholar
• Bar-Oz B, Moretti ME, Mareels G, G. Reporting bias in retrospective ascertainment of drug-induced embryopathy. Lancet 1999;354:1700-1
   PubMed Web of Science ®Google Scholar
• Bar-Oz B, Moretti ME, Bishai R, Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am J Obstet Gynecol 2000;183:617-20
   PubMed Web of Science ®Google Scholar
• De Santis M, Di Gianantonio E, Cesari E, First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy. Drug Saf 2009;32:239-44
   PubMed Web of Science ®Google Scholar
• Rosa FW. Drugs in pregnancy and lactation. Michigan Medicaid Surveillance Study. 1993
   Google Scholar
• Kazy Z, Puhó E, Czeizel AE. Population-based case-control study of oral ketoconazole treatment for birth outcomes. Congenit Anom (Kyoto) 2005;45:5-8
   PubMedGoogle Scholar
• Carter TC, Druschel CM, Romitti PA, Antifungal drugs and the risk of selected birth defects. Am J Obstet Gynecol 2008;198:191;e1-7
   Google Scholar
• Kazy Z, Puhó E, Czeizel AE. Teratogenic potential of vaginal metronidazole treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 2005;123:174-8
   PubMed Web of Science ®Google Scholar
• Czeizel AE, Kazy Z, Puhó E. Population-based case-control teratologic study of topical miconazole. Congenit Anom (Kyoto) 2004;44:41-5
   PubMedGoogle Scholar
• Kazy Z, Puhó E, Czeizel AE. The possible association between the combination of vaginal metronidazole and miconazole treatment and polysyndactyly. Population-based case-control teratologic study. Reprod Toxicol 2005;20:89-94
   PubMed Web of Science ®Google Scholar
• EMEA 2008. Available from: www.emea.europa.eu/htm
   Google Scholar
• Shepard TH. Proof of human teratogenicity. Teratology 1994;50:97-8
   PubMedGoogle Scholar
• Carey JC, Martinez L, Balken E, Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines. Birth Defects Res A Clin Mol Teratol 2009;85:63-8
   PubMed Web of Science ®Google Scholar
• Lopez-Rangel E, Van Allen MI. Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. Birth Defects Res A 2005;73:919-23
   PubMed Web of Science ®Google Scholar
• Reiners J, Wittfoht W, Nau H, Teratogenesis and pharmacokinetics of cyclophosphamide after drug infusion as compared to injection in the mouse during day 10 of gestation. In: Nau H, Scott WJ Jr, editor, Experimental aspects in vivo and in vitro. Pharmacokinetics in teratogenesis. (Volume 2). CRC Press, Boca Raton; 1987. p. 41-8
   Google Scholar
• Nau H. Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse. Toxicol Appl Pharmacol 1985;80:243-50
   PubMed Web of Science ®Google Scholar
• Ornoy A. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 2009;28:1-10
   PubMed Web of Science ®Google Scholar
• Tiboni GM, Giampietro F. Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence. Pediatr Res 2005;58:94-9
   PubMed Web of Science ®Google Scholar
• Tiboni GM, Marotta F, Del Corso A, Defining critical periods for itraconazole-induced cleft palate, limb defects and axial skeletal malformations in the mouse. Toxicol Lett 2006;167:8-18
   PubMed Web of Science ®Google Scholar
• Farag AT, Ibrahim HH. Developmental toxic effects of antifungal flusilazole administered by gavage to mice. Birth Defects Res B Dev Reprod Toxicol 2007;80:12-7
   PubMed Web of Science ®Google Scholar
• Amaral VCS, Nunes GP Jr. Ketoconazole-and Xuconazole-induced embryotoxicity and skeletal anomalies in Wistar rats: a comparative study. Braz Arch Biol Technol 2008;51:1153-61
   Web of Science ®Google Scholar
• Amaral VC, Nunes GP Jr. Prednisone reduces ketoconazole-induced skeletal defects in rat fetuses. Arch Toxicol 2009;83:863-71
   PubMed Web of Science ®Google Scholar
• Nishikawa S, Hara T, Miyazaki H, Reproduction studies of KW-1414 in rats and rabbits. Clin Rep 1984;18:1433-88
   Google Scholar
• Machera K. Developmental toxicity of cyproconazole, an inhibitor of fungal ergosterol biosynthesis, in the rat. Bull Environ Contam Toxicol 1995;54:363-9
   PubMed Web of Science ®Google Scholar
• Menegola E, Di Renzo F, Broccia ML, Cleft palate and exposure to an azole derivative: triadimefon. Reprod Toxicol 2009;28:123
   Google Scholar
• Menegola E, Broccia ML, Di Renzo F, Relationship between hindbrain segmentation, neural crest cell migration and branchial arch abnormalities in rat embryos exposed to fluconazole and retinoic acid in vitro. Reprod Toxicol 2004;18:121-30
   PubMed Web of Science ®Google Scholar
• Tiboni GM, Marotta F, Castigliego AP. Teratogenic effects in mouse fetuses subjected to the concurrent in utero exposure to miconazole and metronidazole. Reprod Toxicol 2008;26:254-61
   PubMed Web of Science ®Google Scholar
• Taxvig C, Vinggaard AM, Hass U, Endocrine-disrupting properties in vivo of widely used azole fungicides. Int J Androl 2008;31:170-7
   PubMed Web of Science ®Google Scholar
• Augustine-Rauch K. Alternative experimental approaches for interpreting skeletal findings in safety studies. Birth Defects Res B Dev Reprod Toxicol 2007;80:497-504
   PubMed Web of Science ®Google Scholar
• Flick B, Klug S. Whole embryo culture: an important tool in developmental toxicology today. Curr Pharm Des 2006;12:1467-88
   PubMed Web of Science ®Google Scholar
• Menegola E, Broccia ML, Di Renzo F, Dysmorphogenic effects of some fungicides derived from the imidazole on rat embryos cultured in vitro. Reprod Toxicol 2006;21:74-82
   PubMed Web of Science ®Google Scholar
• Tiboni GM. Second branchial arch anomalies induced by fluconazole, a bis-triazole antifungal agent, in cultured mouse embryos. Res Commun Chem Pathol Pharmacol 1993;79:381-4
   PubMedGoogle Scholar
• Menegola E, Broccia ML, Di Renzo F, Antifungal triazoles induce malformations in vitro. Reprod Toxicol 2001;15:421-7
   PubMed Web of Science ®Google Scholar
• Menegola E, Broccia ML, Di Renzo F, Pathogenic pathways in fluconazole-induced branchial arch malformations. Birth Defects Res A Clin Mol Teratol 2003;67:116-24
   PubMed Web of Science ®Google Scholar
• Menegola E, Broccia ML, Di Renzo F, Study on the common teratogenic pathway elicited by the fungicides triazole-derivatives. Toxicol In Vitro 2005;19:737-48
   PubMed Web of Science ®Google Scholar
• Zega G, De Bernardi F, Groppelli S, Effects of the azole fungicide Imazalil on the development of the ascidian Ciona intestinalis (chordata, tunicata): morphological and molecular characterization of the induced phenotype. Aquat Toxicol 2009;91:255-61
   PubMed Web of Science ®Google Scholar
• Pennati R, Groppelli S, Zega G, Toxic effects of two pesticides, imazalil and triadimefon, on the early development of the ascidian Phallusia mammillata (chordata, ascidiacea). Aquat Toxicol 2006;79:205-12
   PubMed Web of Science ®Google Scholar
• Menegola E, Broccia ML, Di Renzo F, In vitro teratogenic potential of two antifungal triazoles: triadimefon and triadimenol. In Vitro Cell Dev Biol Anim 2000;36:88-95
   PubMed Web of Science ®Google Scholar
• Kaufman MH, Bard JBL. The anatomical basis of mouse development. Academic Press, San Diego; 1999
   Google Scholar
• Groppelli S, Pennati R, De Bernardi F, Teratogenic effects of two antifungal triazoles, triadimefon and triadimenol, on Xenopus laevis development: craniofacial defects. Aquat Toxicol 2005;73:370-81
   PubMed Web of Science ®Google Scholar
• Nelson DR, Zeldin DC, Hoffman SM, Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 2004;14:1-18
   PubMedGoogle Scholar
• Choudhary D, Jansson I, Stoilov I, Expression patterns of mouse and human CYP orthologs (families 1 – 4) during development and in different adult tissues. Arch Biochem Biophys 2005;436:50-61
   PubMed Web of Science ®Google Scholar
• Stoilov I. Cytochrome P450s: coupling development and environment. Trends Genet 2001;17:629-32
   PubMed Web of Science ®Google Scholar
• Libby RT, Kitamoto J, Holme RH, Cdh23 mutations in the mouse are associated with retinal dysfunction but not retinal degeneration. Exp Eye Res 2003;77:731-9
   PubMed Web of Science ®Google Scholar
• McCaffery P, Simons C. Prospective teratology of retinoic acid metabolic blocking agents (RAMBAs) and loss of CYP26 activity. Curr Pharm Des 2007;13:3020-37
   PubMed Web of Science ®Google Scholar
• Yaffe SJ, Rane A, Sjöqvist F, The presence of a monooxygenase system in human fetal liver microsomes. Life Sci II 1970;9:1189-200
   PubMedGoogle Scholar
• Sun G, Thai SF, Lambert GR, Fluconazole-induced hepatic cytochrome P450 gene expression and enzymatic activities in rats and mice. Toxicol Lett 2006;164:44-53
   PubMed Web of Science ®Google Scholar
• Vinggaard AM, Hnida C, Breinholt V, Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. Toxicol In Vitro 2004;14:227-34
   Google Scholar
• Colburn DE, Giles FJ, Oladovich D, In vitro evaluation of cytochrome P450-mediated drug interactions between cytarabine, idarubicin, itraconazole and caspofungin. Hematology 2004;9:217-21
   PubMedGoogle Scholar
• Venkatakrishnan K, von Moltke LL, Greenblatt DJ. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance. Clin Pharmacokinet 2000;38:111-80
   PubMed Web of Science ®Google Scholar
• Niwa T, Shiraga T, Takagi A. Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull 2005;28:1805-8
   PubMed Web of Science ®Google Scholar
• Gyllenhammar I, Eriksson H, Söderqvist A, Clotrimazole exposure modulates aromatase activity in gonads and brain during gonadal differentiation in Xenopus tropicalis frogs. Aquat Toxicol 2009;91:102-9
   PubMed Web of Science ®Google Scholar
• Engelhardt D, Weber MM, Miksch T, The influence of ketoconazole on human adrenal steroidogenesis: incubation studies with tissue slices. Clin Endocrinol (Oxf) 1991;35:163-8
   PubMed Web of Science ®Google Scholar
• AHFS, (American Hospital Formulary Service), Drug Information. American Society of Health-System Pharmacists, Bethesda MD; 1996
   Google Scholar
• Iranmanesh A, Ovetsky RM, Lizarralde G, Effect of ketoconazole on the 11-hydroxylation step of adrenal steroidogenesis. South Med J 1987;80:725-8
   PubMed Web of Science ®Google Scholar
• Tiboni GM, Iammarrone E, Giampietro F, Teratological interaction between the bis-triazole antifungal agent fluconazole and the anticonvulsant drug phenytoin. Teratology 1999;59:81-7
   PubMedGoogle Scholar
• Schwartz EL, Hallam S, Gallagher RE, Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. Biochem Pharmacol 1995;50:923-8
   PubMed Web of Science ®Google Scholar
• Vanier KL, Mattiussi AJ, Johnston DL. Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemia. J Pediatr Hematol Oncol 2003;25:403-4
   PubMed Web of Science ®Google Scholar
• Kirby AJ, Le Lain R, Maharlouie F, Inhibition of retinoic acid metabolising enzymes by 2-(4-aminophenylmethyl)-6-hydroxy-3,4-dihydronaphthalen-1(2H)-one and related compounds. J Enzyme Inhib Med Chem 2003;18:27-33
   PubMed Web of Science ®Google Scholar
• Wouters W, van Dun J, Dillen A, Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells. Cancer Res 1992;52:2841-6
   PubMed Web of Science ®Google Scholar
• Pignatello MA, Kauffman FC, Levin AA. Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures: a model to explain the potency of the aromatic retinoid (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-propenyl] benzoic acid. Toxicol Appl Pharmacol 2002;178:186-94
   PubMed Web of Science ®Google Scholar
• Van Wauwe J, Van Nyen G, Coene MC, Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo. J Pharmacol Exp Ther 1992;261:773-9
   PubMed Web of Science ®Google Scholar
• Van Heusden J, Van Ginckel R, Bruwiere H, Inhibition of all-trans-retinoic acid metabolism by R116010 induces antitumour activity. Br J Cancer 2002;86:605-11
   PubMed Web of Science ®Google Scholar
• Pavez Loriè E, Cools M, Borgers M, Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis. Br J Dermatol 2009;160:26-36
   PubMed Web of Science ®Google Scholar
• Campo-Paysaa F, Marlétaz F, Laudet V, Retinoic acid signaling in development: tissue-specific functions and evolutionary origins. Genesis 2008;46:640-56
   PubMed Web of Science ®Google Scholar
• White JC, Highland M, Kaiser M, Vitamin A deficiency results in the dose-dependent acquisition of anterior character and shortening of the caudal hindbrain of the rat embryo. Dev Biol 2000;220:263-84
   PubMed Web of Science ®Google Scholar
• Niederreither K, Vermot J, Schuhbaur B, Retinoic acid synthesis and hindbrain patterning in the mouse embryo. Development 2000;127:75-85
   PubMed Web of Science ®Google Scholar
• Morriss-Kay GM, Murphy P, Hill RE, Effects of retinoic acid excess on expression of Hox-2.9 and Krox-20 and on morphological segmentation in the hindbrain of mouse embryos. EMBO J 1991;10:2985-95
   PubMed Web of Science ®Google Scholar
• Armstrong RB, Kim HJ, Grippo JF, Levin AA. Retinoids for the future: investigational approaches for the identification of new compounds. J Am Acad Dermatol 1992;27:S38-42
   PubMed Web of Science ®Google Scholar
• Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996;10:940-54
   PubMed Web of Science ®Google Scholar
• Niederreither K, Vermot J, Fraulob V, Retinaldehyde dehydrogenase 2 (RALDH2)- independent patterns of retinoic acid synthesis in the mouse embryo. Proc Natl Acad Sci USA 2002;99:16111-6
   PubMed Web of Science ®Google Scholar
• Abu-Abed SS, Beckett BR, Chiba H, Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha. J Biol Chem 1998;273:2409-15
   PubMed Web of Science ®Google Scholar
• MacLean G, Abu-Abed S, Dollé P, Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis with Cyp26A1 during early murine development. Mech Dev 2001;107:195-201
   PubMed Web of Science ®Google Scholar
• Reijntjes S, Blentic A, Gale E, The control of morphogen signalling: regulation of the synthesis and catabolism of retinoic acid in the developing embryo. Dev Biol 2005;285:224-37
   PubMed Web of Science ®Google Scholar
• Wang Y, Zolfaghari R, Ross AC. Cloning of rat cytochrome P450RAI (CYP26) cDNA and regulation of its gene expression by all-trans-retinoic acid in vivo. Arch Biochem Biophys 2002;401:235-43
   PubMed Web of Science ®Google Scholar
• Tahayato A, Dollé P, Petkovich M. Cyp26C1 encodes a novel retinoic acid-metabolizing enzyme expressed in the hindbrain, inner ear, first branchial arch and tooth buds during murine development. Gene Expr Patterns 2003;3:449-54
   PubMed Web of Science ®Google Scholar
• Reijntjes S, Gale E, Maden M. Expression of the retinoic acid catabolising enzyme CYP26B1 in the chick embryo and its regulation by retinoic acid. Gene Expr Patterns 2003;3:621-7
   PubMed Web of Science ®Google Scholar
• Reijntjes S, Gale E, Maden M. Generating gradients of retinoic acid in the chick embryo: Cyp26C1 expression and a comparative analysis of the Cyp26 enzymes. Dev Dyn 2004;230:509-17
   PubMed Web of Science ®Google Scholar
• de Roos K, Sonneveld E, Compaan B, Expression of retinoic acid 4-hydroxylase (CYP26) during mouse and Xenopus laevis embryogenesis. Mech Dev 1999;82:205-11
   PubMed Web of Science ®Google Scholar
• Emoto Y, Wada H, Okamoto H, Retinoic acid-metabolizing enzyme Cyp26a1 is essential for determining territories of hindbrain and spinal cord in zebrafish. Dev Biol 2005;278:415-27
   PubMed Web of Science ®Google Scholar
• Cañestro C, Postlethwait JH, Gonzàlez-Duarte R, Is retinoic acid genetic machinery a chordate innovation? Evol Dev 2006;8:394-406
   PubMed Web of Science ®Google Scholar
• Abu-Abed S, MacLean G, Fraulob V, Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis. Mech Dev 2002;110:173-7
   PubMed Web of Science ®Google Scholar
• Uehara M, Yashiro K, Mamiya S, CYP26A1 and CYP26C1 cooperatively regulate anterior-posterior patterning of the developing brain and the production of migratory cranial neural crest cells in the mouse. Dev Biol 2007;302:399-411
   PubMed Web of Science ®Google Scholar
• Santner SJ, Pauley RJ, Tait L, Aromatase activity and expression in breast cancer and benign breast tissue stromal cells. J Clin Endocrinol Metab 1997;82:200-8
   PubMed Web of Science ®Google Scholar
• Buzdar AU, Robertson JF, Eiermann W, An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane. Cancer 2002;95:2006-16
   PubMed Web of Science ®Google Scholar
• Tiboni GM, Marotta F, Carletti E. Fluconazole alters CYP26 gene expression in mouse embryos. Reprod Toxicol 2009;27:199-202
   PubMed Web of Science ®Google Scholar
• Klug S, Lewandowski C, Wildi L, All-trans retinoic acid and 13-cis-retinoic acid in the rat whole-embryo culture: abnormal development due to the all-trans isomer. Arch Toxicol 1989;63:440-4
   PubMed Web of Science ®Google Scholar
• Di Renzo F, Broccia ML, Giavini E, Citral, an inhibitor of retinoic acid synthesis, attenuates the frequency and severity of branchial arch abnormalities induced by triazole-derivative fluconazole in rat embryos cultured in vitro. Reprod Toxicol 2007;24:326-32
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Zolfaghari R, Ross AC. Regulation of CYP26 (cytochrome P450RAI) mRNA expression and retinoic acid metabolism by retinoids and dietary vitamin A in liver of mice and rats. FASEB J 2000;14:2119-27
   PubMed Web of Science ®Google Scholar
• White RJ, Schilling TF. How degrading: Cyp26s in hindbrain development. Dev Dyn 2008;237:2775-90
   PubMed Web of Science ®Google Scholar
• Dobbs-McAuliffe B, Zhao Q, Linney E. Feedback mechanisms regulate retinoic acid production and degradation in the zebrafish embryo. Mech Dev 2004;121:339-50
   PubMed Web of Science ®Google Scholar
• White RJ, Nie Q, Lander AD, Complex regulation of cyp26a1 creates a robust retinoic acid gradient in the zebrafish embryo. PLoS Biol 2007;5:e304
   PubMed Web of Science ®Google Scholar
• Serpente P, Tümpel S, Ghyselinck NB, Direct crossregulation between retinoic acid receptor {beta} and Hox genes during hindbrain segmentation. Development 2005;132:503-13
   PubMed Web of Science ®Google Scholar
• Taimi M, Helvig C, Wisniewski J, A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid. J Biol Chem 2004;279:77-85
   PubMed Web of Science ®Google Scholar
• Papis E, Bernardini G, Gornati R, Gene expression in Xenopus laevis embryos after triadimefon exposure. Gene Expr Patterns 2007;7:137-42
   PubMed Web of Science ®Google Scholar
• Chai Y, Ito Y, Han J. TGF-beta signaling and its functional significance in regulating the fate of cranial neural crest cells. Crit Rev Oral Biol Med. 2003;14:78-88
   PubMedGoogle Scholar
• Colakoglu N, Kukner A, Oner J, Effects of high dose retinoic acid on TGF-beta2 expression during pancreatic organogenesis. J Mol Histol 2005;36:413-8
   PubMed Web of Science ®Google Scholar
• Di Renzo F, Corsini E, Broccia ML, Molecular mechanism of teratogenic effects induced by the fungicide triadimefon: study of the expression of TGF-beta mRNA and TGF-beta and CRABPI proteins during rat in vitro development. Toxicol Appl Pharmacol 2009;234:107-16
   PubMed Web of Science ®Google Scholar
• Chen F, Desai TJ, Qian J, Inhibition of Tgf beta signaling by endogenous retinoic acid is essential for primary lung bud induction. Development 2007;134:2969-79
   PubMed Web of Science ®Google Scholar
• Massa V, Gaudenzi G, Sangiorgio L, Krox20 is down-regulated following triazole in vitro embryonic exposure: a polycompetitor-based assay. Toxicol Lett 2007;169:196-204
   PubMed Web of Science ®Google Scholar
• De S, Turman JE Jr. Krox-20 gene expression: influencing hindbrain-craniofacial developmental interactions. Arch Histol Cytol 2005;68:227-34
   PubMed Web of Science ®Google Scholar
• Borday C, Chatonnet F, Thoby-Brisson M, Neural tube patterning by Krox20 and emergence of a respiratory control. Respir Physiol Neurobiol 2005;149:63-72
   PubMed Web of Science ®Google Scholar
• Warner LE, Mancias P, Butler IJ, Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998;18:382-4
   PubMed Web of Science ®Google Scholar
• Chun K, Siegel-Bartelt J, Chitayat D, FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am J Med Genet 1998;77:219-24
   PubMed Web of Science ®Google Scholar
• Reardon W. Craniosynostosis. Diagnosis, evaluation and management. J Med Genet 2000;37:727
   PubMedGoogle Scholar
• Adachi M, Asakura Y, Tachibana K, Abnormal steroidogenesis in three patients with Antley-Bixler syndrome: apparent decreased activity of 17alpha-hydroxylase, 17,20-lyase and 21-hydroxylase. Pediatr Int 2004;46:583-9
   PubMed Web of Science ®Google Scholar
• Flück CE, Tajima T, Pandey AV, Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 2004;36:228-30
   PubMed Web of Science ®Google Scholar
• Aleck KA, Bartley DL. Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. Am J Med Genet 1997;72:253-6
   PubMed Web of Science ®Google Scholar
• Csapo A, Dray F, Erdos T. Letter: oestradiol 17beta: inhibitor of placental growth. Lancet 1974;6:51-2
   Google Scholar
• Furukawa S, Hayashi S, Usuda K, Histopathological effect of ketoconazole on rat placenta. Vet Med Sci 2008;70:1179-84
   PubMed Web of Science ®Google Scholar
• Pasanen M, Pellinen P, Stenbäck F, The role of CYP enzymes in cocaine-induced liver damage. Arch Toxicol 1995;69:287-90
   PubMed Web of Science ®Google Scholar
• Tiboni GM, Marotta F, Castigliego AP, Impact of estrogen replacement on letrozole-induced embryopathic effects. Hum Reprod 2009;24(11):2688-92
   PubMed Web of Science ®Google Scholar